ARPA‑H Launches SPECTRA Program to Transform Autism Diagnosis with AI Precision

ARPA‑H launches the SPECTRA program, a new federal effort to transform autism diagnosis using advanced technologies and precision‑care methods. The agency announced the initiative at a press briefing, emphasizing the need for faster, more accurate assessments for children and adults across the United States.

SPECTRA will combine AI‑driven imaging, genetic biomarkers, and large‑scale data analytics to detect autism spectrum traits at earlier stages. Researchers plan to fuse brain‑scan visuals with DNA markers and machine‑learning models, creating individualized diagnostic profiles that guide personalized therapy decisions.

The initiative expects to cut diagnostic delays, accelerate research timelines, and forge partnerships with leading academic hospitals and biotech firms. Federal funding will support pilot studies in several clinics, aiming to deliver scalable diagnostic tools nationwide within the next five years.

Healthcare providers anticipate that SPECTRA’s AI‑enhanced diagnostics will improve early intervention rates, reduce long‑term care costs, and generate new research data for autism therapies. The program also includes training modules for clinicians to interpret AI outputs reliably.